Radioimmunoassay Market worth $428.4 Million by 2020 - PowerPoint PPT Presentation

About This Presentation
Title:

Radioimmunoassay Market worth $428.4 Million by 2020

Description:

The global radioimmunoassay (RIA) market was valued at $345.2 Million in 2014 and is expected to reach $428.4 Million by 2020, at a CAGR of 3.5% during the forecast period from 2015 to 2020. – PowerPoint PPT presentation

Number of Views:17
Slides: 8
Provided by: POONAM26
Category:
Tags:

less

Transcript and Presenter's Notes

Title: Radioimmunoassay Market worth $428.4 Million by 2020


1
MarketsandMarkets Presents
Radioimmunoassay Market worth 428.4 Million by
2020
http//www.marketsandmarkets.com/Market-Reports/ra
dioimmunoassay-market-172815697.html
2
The report "Radioimmunoassay Market by Type
(Reagents Kits, Analyzers), End User (Hospital,
Pharmaceutical Industry, Academics, Clinical
Diagnostic Labs), Application (Research, Clinical
Diagnostics), and Geography - Global Forecast to
2020", The global radioimmunoassay (RIA) market
was valued at 345.2 Million in 2014 and is
expected to reach 428.4 Million by 2020, at a
CAGR of 3.5 during the forecast period from 2015
to 2020.   Browse 75 market data Tables and 68
Figures spread through 113 Pages and in-depth TOC
on Radioimmunoassay Market http//www.marketsandm
arkets.com/Market-Reports/radioimmunoassay-market-
172815697.html Early buyers will receive 10
customization on This report.   Radioimmunoassay
(RIA) is an in-vitro assay technique that is used
to measure the concentration of antigens in
blood. RIA encompasses the separation of protein
from a mixture by using the specificity of
antibody- antigen binding and their quantitation
by using radioactivity. The method is
hypersensitive and can quantify tiny amounts of
hormone or drug level with the help of antibodies.
http//www.marketsandmarkets.com/Market-Reports/ra
dioimmunoassay-market-172815697.html
3
Radioimmunoassay is used owing to its high
sensitivity, which can analyze nanomolar and
picomolar concentrations of hormones in
biological fluids. RIA has become one of the
major tools in various clinical laboratories for
diagnostic procedures, such as assessing the
plasma levels of most of the hormones,
identifying the presence of certain abused drugs,
evaluating the presence of hepatitis B surface
antigen in donated blood, and others. This
technique is also used for the early detection of
cancer, treatment of peptic ulcers, research with
neurotransmitters, detection of infections, and
identification of allergens in food and house
dust, and so on. The increasing usage of RIA in
pharmaceutical industries, research labs, and
contract research organizations (CROs) has led to
an increased demand of products that are based on
this technique. Furthermore, the rising need for
quality and error-free results to ensure patient
satisfaction has resulted in research labs and
diagnostic centers to opt for high-throughput and
automated procedures. This is also one of the
major factors that have resulted in the growth of
the RIA market to a large extent.
http//www.marketsandmarkets.com/Market-Reports/ra
dioimmunoassay-market-172815697.html
4
There are two types of radioimmunoassay, which
serve different functions for clinical
diagnostics The various application areas of RIA
are infectious disease testing, endocrine
testing, allergy testing, oncology testing,
toxicology testing, and autoimmune disease
testing. Out of all the application segments,
oncology testing is the largest application
segment, and is expected to hold the major market
share in the near future. The Sample Report For
This Report_at_ http//www.marketsandmarkets.com/req
uestsample.asp?id172815697 Based on this
markets end users, the global radioimmunoassay
market has been segmented into hospitals
(hospital-based laboratories/hospital-attached
laboratories), academics, pharmaceutical industry
and CROs, clinical laboratories, and others,
which include physician offices, patient
self-testing centers, blood banks, home health
agencies, nursing homes, and ambulatory surgical
centers.  
http//www.marketsandmarkets.com/Market-Reports/ra
dioimmunoassay-market-172815697.html
5
The global radioimmunoassay market has been
categorized into major geographical regions,
including Europe, North America, Asia, and the
Rest of the world. Europe is the most dominant
region in the global radioimmunoassay market, and
contributed a share of 35.1 in 2014 the market
in this region was valued at 121.5 Million in
the same year. Get The PDF Brochure For This
Report_at_ http//www.marketsandmarkets.com/pdfdownlo
ad.asp?id172815697 Some of the major players in
the radioimmunoassay globally are DIAsource
ImmunoAssays SA (Belgium), Beckman Coulter, Inc.
(U.S.), IBL International (A Tecan Company)
(Germany), PerkinElmer, Inc. (U.S.), DRG
International, Inc. (U.S.), MP Biomedicals, LLC
(U.S.), Cisbio (France), Euro Diagnostica AB
(Sweden), DiaSorin S.p.A.. (Italy), EMD Millipore
(U.S.), Izotop (Hungary), Berthold Technologies
GmbH Co. KG (Germany), Stratec Biomedical AG
(Germany), and others.      
http//www.marketsandmarkets.com/Market-Reports/ra
dioimmunoassay-market-172815697.html
6
About MarketsandMarkets MarketsandMarkets
provides quantified B2B research on 30,000 high
growth niche opportunities/threats which will
impact 70 to 80 of worldwide companies
revenues. Currently servicing 5000 customers
worldwide including 80 of global Fortune 1000
companies as clients. Almost 75,000 top officers
across eight industries worldwide approach
MarketsandMarkets for their painpoints around
revenues decisions.   Our 850 fulltime analyst
and SMEs at MarketsandMarkets are tracking
global high growth markets following the "Growth
Engagement Model GEM". The GEM aims at
proactive collaboration with the clients to
identify new opportunities, identify most
important customers, write "Attack, avoid and
defend" strategies, identify sources of
incremental revenues for both the company and its
competitors. MarketsandMarkets now coming up
with 1,500 MicroQuadrants (Positioning top
players across leaders, emerging companies,
innovators, strategic players) annually in high
growth emerging segments. MarketsandMarkets is
determined to benefit more than 10,000 companies
this year for their revenue planning and help
them take their innovations/disruptions early to
the market by providing them research ahead of
the curve.   MarketsandMarketss flagship
competitive intelligence and market research
platform, "RT" connects over 200,000 markets and
entire value chains for deeper understanding of
the unmet insights along with market sizing and
forecasts of niche markets.   
http//www.marketsandmarkets.com/Market-Reports/ra
dioimmunoassay-market-172815697.html
7
Contact Us
Mr. Rohan MarketsandMarkets 701 Pike Street
Suite 2175, Seattle, WA 98101, United States
Tel 1-888-600-6441 Email sales_at_marketsandmarket
s.com MarketsandMarkets Bloghttp//www.marketsan
dmarkets.comhttp//twitter.com/marketsmarkets htt
p//www.linkedin.com/company/marketsandmarkets
Write a Comment
User Comments (0)
About PowerShow.com